STOCK TITAN

Auxly Cannabis Stock Price, News & Analysis

CBWTF OTC

Welcome to our dedicated page for Auxly Cannabis news (Ticker: CBWTF), a resource for investors and traders seeking the latest updates and insights on Auxly Cannabis stock.

Auxly Cannabis Group Inc. (OTCQB: CBWTF; TSX: XLY) generates frequent news as a Canadian consumer packaged goods company focused on cannabis products. Company updates center on its branded dried flower, pre-roll and vape offerings, its financial performance, and developments in its capital structure.

News items often cover quarterly and interim financial results, where Auxly reports on net revenues, gross margin on finished cannabis inventory sold, adjusted EBITDA and net income. These releases also highlight commercial metrics such as national market share, category leadership in all-in-one vapes and non-infused pre-rolls, and the performance of key brands like Back Forty, Liquid Imagination and Fire Breath.

Auxly’s news flow also includes announcements about strategic and financial transactions. Examples include amendments and extensions to its credit facility with a syndicate of lenders led by the Bank of Montreal, the settlement of amounts owing to Imperial Brands plc through equity and pre-funded warrants, and the repayment of specific inventory loans. The company presents these developments as steps that reduce debt, lower interest expense and strengthen its balance sheet.

Operational and corporate updates can feature product and brand innovations, such as the launch of Back Forty Backpackers pre-rolls and the introduction of the South Point brand, as well as expansion into new provincial markets like Quebec. Governance and shareholder-related items, including annual meeting results and board elections, are also disclosed through news releases.

Investors and observers following CBWTF news can use this page to track Auxly’s earnings reports, capital structure changes, brand and product announcements, and other corporate communications that the company distributes through wire services.

Rhea-AI Summary

Auxly (OTCQB: CBWTF) reported 2025 results with net revenue $151.5M (+24%) and Adjusted EBITDA $43.8M (+64%). Gross Margin on Finished Cannabis Inventory Sold improved to 54%. Full-year net income was $41.9M. Year-end cash totaled $32.3M with Total Debt/Adjusted EBITDA of 1.1x. Management plans $10–12M capital spend in 2026 and became a DIP lender/stalking horse bidder for Ayurcann assets. Q4 revenue was $40.1M (+16%) with Adjusted EBITDA margin ~31%.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.98%
Tags
-
Rhea-AI Summary

Auxly (OTCQB: CBWTF) reviewed 2025 milestones and issued a 2026 outlook, highlighting product innovation, distribution gains and improved financials. Key 2025 results include TTM net revenue $146M, Adjusted EBITDA $42M, and Q3 2025 net revenue of $39.9M (+20% YoY). Gross margin on finished cannabis inventory sold rose to 56% from 47% and Q3 Adjusted EBITDA reached $12.3M (31% margin). Balance sheet improvements include positive working capital $49M with $30M cash and Total Debt/Adjusted EBITDA of 1.3x (0.6x net-of-cash). Auxly plans $10–12M capex in 2026 to expand Leamington capacity and prepare for international shipments.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.73%
Tags
none
-
News
Rhea-AI Summary

Auxly (OTCQB: CBWTF) reported Q3 2025 results on November 13, 2025. Key metrics: net revenues $39.9M (+20% YoY), Adjusted EBITDA $12.3M (+48% YoY, 31% margin), and net income $20.5M (+533% YoY). Gross margin on finished cannabis inventory sold improved to 56% from 47% a year earlier. Cash at quarter end totaled $30.5M (up 66% YoY). Year-to-date net revenues were $111.4M (+27%) and Adjusted EBITDA $31.2M (+99%).

The company cited higher volumes, improved pricing, manufacturing efficiencies and a gain on the Imperial Debenture settlement as drivers. Auxly plans $2.0–$2.5M of 2025 capex and to prioritize free-cash-flow-funded growth, deleveraging, and potential strategic initiatives.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-10.18%
Tags
Rhea-AI Summary

Auxly Cannabis Group (OTCQB: CBWTF; TSX: XLY) will report third-quarter and nine-month 2025 results for the period ended September 30, 2025 on Thursday, November 13, 2025 before markets open.

The company's regulatory filing, press release and shareholder letter will be available on its website, and shareholders or prospective investors may contact management by the e-mail address provided by the company. The announcement is signed on behalf of the board by Hugo Alves, CEO.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.37%
Tags
earnings date
-
News
Rhea-AI Summary

Auxly Cannabis Group (OTCQB: CBWTF, TSX: XLY) announced on Oct 27, 2025 that it repaid in full a $5 million inventory loan owed to GrassHopper Capital using cash on hand. The company expects annualized interest expense savings of approximately $900,000 as a result.

Management said revenue growth and operating leverage have produced free cash flow, allowing Auxly to prioritize organic investment and strengthen the balance sheet by eliminating the loan and reducing recurring interest costs.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.4%
Tags
none
-
Rhea-AI Summary

Auxly (OTCQB: CBWTF / TSX: XLY) will present at the Planet MicroCap Showcase: Toronto on Wednesday, October 22, 2025 at 11:30 AM EST at Arcadian Loft in Downtown Toronto.

Hugo Alves, Chief Executive Officer, will host the presentation and answer questions. A live webcast will be available via the conference platform under the event Agenda tab. Investors may register for the conference and request 1x1 meetings through the provided registration link.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.94%
Tags
conferences
Rhea-AI Summary

Auxly Cannabis Group (TSX: XLY) held its annual general and special meeting on June 30, 2025, with 28.23% shareholder participation representing 371,890,083 common shares. All proposed matters received majority approval from shareholders.

The meeting resulted in the successful election of all nominated directors with strong support: Genevieve Young (99.39%), Hugo Alves (99.36%), Troy Grant (99.43%), Vikram Bawa (99.30%), and Conrad Tate (99.41%). Shareholders also approved the reappointment of Ernst & Young LLP as the company's auditors for fiscal year 2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.52%
Tags
-
Rhea-AI Summary

Auxly Cannabis Group (OTCQB: CBWTF) reported strong Q2 2025 financial results with significant year-over-year improvements. Net revenues reached $38.8 million, up 33% YoY, while gross margin improved to 52% from 41% in Q2 2024. The company achieved net income of $8.3 million, a 315% increase YoY, and Adjusted EBITDA of $11.6 million, representing 30% of net revenue.

The company strengthened its market position as the #3 largest Canadian Licensed Producer with 6.2% market share. Back Forty became the #1 cannabis brand in Canada, with their Liquid Imagination and Fire Breath 28g products leading national sales. Post-quarter, Auxly enhanced its balance sheet through debt amendments and Imperial Brands' debt-to-equity conversion, reducing the pro forma Total Debt to TTM Adjusted EBITDA to 1.4x.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.9%
Tags
-
Rhea-AI Summary

Auxly Cannabis Group (OTCQB:CBWTF) has scheduled its Q2 2025 earnings release for August 14, 2025, before market open. The company will report results for both the second quarter and the six-month period ending June 30, 2025.

The company announced it will not hold an earnings conference call and does not plan to reinstate earnings calls in the near future. Investors are directed to send their inquiries to IR@auxly.com.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.36%
Tags
conferences earnings
Rhea-AI Summary

Auxly Cannabis Group (OTCQB: CBWTF) has successfully completed two transformative financial transactions that significantly strengthen its balance sheet and financial position. The company has eliminated $21 million in debt and secured an amended credit facility with BMO, which includes a $36.2 million term loan and a $10 million revolving facility.

The company has also settled all obligations with Imperial Brands through a combination of share conversions and warrant issuances. This settlement included converting $1 million principal amount into shares at $0.81 per share, converting $1.39 million of accrued interest into shares at $0.0811 per share, and issuing warrants for 90.8 million shares in exchange for approximately $7.37 million of additional interest, with $11.79 million in remaining interest forgiven.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
19.05%
Tags
none

FAQ

What is the current stock price of Auxly Cannabis (CBWTF)?

The current stock price of Auxly Cannabis (CBWTF) is $0.0931 as of April 2, 2026.

What is the market cap of Auxly Cannabis (CBWTF)?

The market cap of Auxly Cannabis (CBWTF) is approximately 125.4M.

CBWTF Rankings

CBWTF Stock Data

125.40M
1.04B
Drug Manufacturers - Specialty & Generic
Healthcare
Link
Canada
Toronto

CBWTF RSS Feed